Skip to main content
. 2016 Dec 12;12:2694–2718. doi: 10.3762/bjoc.12.267

Figure 3.

Figure 3

(a) The crystal structure showing the binding of Dorzolamide (orange) to carbonic anhydrase II (purple) (4M2U) (b) the structure of Dorzolamide. Dorzolamide is an FDA approved drug that targets carbonic anhydrase II to treat patience with glaucoma.